BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 7886013)

  • 1. [Cytogenetics and molecular studies confirm the histopathologic diagnosis of chronic myeloproliferative diseases].
    Werner M; Nolte M; Ewing M; Kaloutsi V; Kausche F; Georgii A
    Pathologe; 1995 Jan; 16(1):41-5. PubMed ID: 7886013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative analysis of FISH, RT-PCR, and cytogenetics for the diagnosis of bcr-abl-positive leukemias.
    Cox MC; Maffei L; Buffolino S; Del Poeta G; Venditti A; Cantonetti M; Aronica G; Aquilina P; Masi M; Amadori S
    Am J Clin Pathol; 1998 Jan; 109(1):24-31. PubMed ID: 9426514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analysis of interphase FISH and RT-PCR to detect bcr-abl translocation in chronic myelogenous leukemia and related disorders.
    Tbakhi A; Pettay J; Sreenan JJ; Abdel-Razeq H; Kalaycio M; Hoeltge G; Miller ML; Tubbs RR
    Am J Clin Pathol; 1998 Jan; 109(1):16-23. PubMed ID: 9426513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic analysis of chromosome 13 deletions in BCR/ABL negative chronic myeloproliferative disorders.
    Pastore C; Nomdedeu J; Volpe G; Guerrasio A; Cambrin GR; Parvis G; Pautasso M; Daglio C; Mazza U; Saglio G
    Genes Chromosomes Cancer; 1995 Oct; 14(2):106-11. PubMed ID: 8527391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenetic mechanisms in chronic myeloproliferative disorders: polycythemia vera, essential thrombocythemia, agnogenic myeloid metaplasia, and chronic myelogenous leukemia.
    Tefferi A
    Semin Hematol; 1999 Jan; 36(1 Suppl 2):3-8. PubMed ID: 9930550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Karyotype findings and molecular analysis of the bcr gene rearrangement supplementing the histologic classification of chronic myeloproliferative disorders.
    Werner M; Nolte M; Kaloutsi V; Buhr T; Kausche F; Georgii A
    Lab Invest; 1995 Apr; 72(4):405-10. PubMed ID: 7723278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Essential thrombocythemia with the Philadelphia chromosome and BCR-ABL gene rearrangement. An entity distinct from chronic myeloid leukemia and Philadelphia chromosome-negative essential thrombocythemia.
    LeBrun DP; Pinkerton PH; Sheridan BL; Chen-Lai J; Dubé ID; Poldre PA
    Cancer Genet Cytogenet; 1991 Jul; 54(1):21-5. PubMed ID: 2065312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of bcr-abl fusion in chronic myelogeneous leukemia by in situ hybridization.
    Tkachuk DC; Westbrook CA; Andreeff M; Donlon TA; Cleary ML; Suryanarayan K; Homge M; Redner A; Gray J; Pinkel D
    Science; 1990 Oct; 250(4980):559-62. PubMed ID: 2237408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translocation of BCR to chromosome 9 in a Philadelphia-negative chronic myeloid leukemia.
    Brunel V; Sainty D; Costello R; Mozziconacci MJ; Simonetti J; Arnoulet C; Coignet L; Bouabdallah R; Gastaut JA; Gabert J
    Cancer Genet Cytogenet; 1995 Nov; 85(1):82-4. PubMed ID: 8536245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence from molecular genetic and cytogenetic analyses that bone marrow histopathology is reliable in the diagnosis of chronic myeloproliferative disorders.
    Werner M; Kaloutsi V; Kausche F; Buhr T; Georgii A
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1993; 63(4):199-204. PubMed ID: 8099457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ABL gene fuses BCR during t(20;22) results in Philadelphia-negative, but BCR/ABL-positive chronic myeloid leukemia.
    Ito Y; Shimamoto T; Kuriyama Y; Nakajima A; Sumi M; Watanabe Y; Beppu H; Ohtsubo K; Ohyashiki K
    Leukemia; 2002 May; 16(5):951-2. PubMed ID: 11986960
    [No Abstract]   [Full Text] [Related]  

  • 12. Megakaryocytes carry the fused bcr-abl gene in chronic myeloid leukaemia: a fluorescence in situ hybridization analysis from bone marrow biopsies.
    Nolte M; Werner M; Ewig M; von Wasielewski R; Link H; Diedrich H; Georgii A
    Virchows Arch; 1996 Mar; 427(6):561-5. PubMed ID: 8605566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular cytogenetics of chronic myeloid leukemia with atypical t(6;9) (p23;q34) translocation.
    Jadayel D; Calabrese G; Min T; van Rhee F; Swansbury GJ; Dyer MJ; Maitland J; Palka G; Catovsky D
    Leukemia; 1995 Jun; 9(6):981-7. PubMed ID: 7596189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow biopsy (BMB). II. Bone marrow biopsy in myeloproliferative disorders.
    Macavei I; Galatâr N
    Morphol Embryol (Bucur); 1989; 35(2):117-27. PubMed ID: 2529429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of the Mbcr/abl translocation in chronic myeloid leukemia by fluorescence in situ hybridization: comparison with conventional cytogenetics and implications for minimal residual disease detection.
    Garcia-Isidoro M; Tabernero MD; Garcia JL; Najera ML; Hernandez JM; Wiegant J; Raap A; San Miguel J; Orfao A
    Hum Pathol; 1997 Feb; 28(2):154-9. PubMed ID: 9023395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. bcr gene rearrangement analysis in myeloproliferative disorders other than chronic myelogenous leukemia.
    Crisan D; Mattson JC; O'Malley BA; Schulz RW; Wilner F
    Cancer Detect Prev; 1996; 20(4):263-9. PubMed ID: 8818385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fusion of H4/D10S170 to the platelet-derived growth factor receptor beta in BCR-ABL-negative myeloproliferative disorders with a t(5;10)(q33;q21).
    Kulkarni S; Heath C; Parker S; Chase A; Iqbal S; Pocock CF; Kaeda J; Cwynarski K; Goldman JM; Cross NC
    Cancer Res; 2000 Jul; 60(13):3592-8. PubMed ID: 10910073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The histopathology of chronic myeloproliferative diseases.
    Georgii A; Buesche G; Kreft A
    Baillieres Clin Haematol; 1998 Dec; 11(4):721-49. PubMed ID: 10640214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of BCR/ABL gene rearrangements by interphase fluorescence in situ hybridization (FISH) in BCR/ABL+ leukemias: incidence and underlying genetic abnormalities.
    Primo D; Tabernero MD; Rasillo A; Sayagués JM; Espinosa AB; Chillón MC; Garcia-Sanz R; Gutierrez N; Giralt M; Hagemeijer A; San Miguel JF; Orfao A
    Leukemia; 2003 Jun; 17(6):1124-9. PubMed ID: 12764379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic myeloid leukemia with a rare variant BCR-ABL translocation: t(9;22;21)(q34;q11.2;q11.2).
    Takeuchi M; Katayama Y; Okamura A; Yamamoto K; Shimoyama M; Matsui T
    Cancer Genet Cytogenet; 2007 Nov; 179(1):85-7. PubMed ID: 17981222
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.